mRNA vaccines in the prevention and treatment of diseases

被引：31

作者：

Gu, Yangzhuo ^{[1
,2
,3
]}

Duan, Jiangyao ^{[4
]}

Yang, Na ^{[5
]}

Yang, Yuxin ^{[5
]}

Zhao, Xing ^{[1
,2
,3
,5
]}

机构：

[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China

[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China

[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China

[4] Imperial Coll London, Dept Life Sci, London, England

[5] Guizhou Med Univ, Sch Basic Med Sci, Stem Cell & Tissue Engn Res Ctr, Guiyang 550004, Guizhou, Peoples R China

来源：

MEDCOMM | 2022年 / 3卷 / 03期

关键词：

cancer; infectious diseases; lipid nanoparticles; mRNA delivery; mRNA vaccine; DENDRITIC CELLS; LIPID NANOPARTICLES; IMMUNE-RESPONSES; SIPULEUCEL-T; PHASE IB; TRANSLATIONAL CONTROL; ANTITUMOR IMMUNITY; ALLERGIC REACTIONS; VACCINATION TRIAL; ADVANCED MELANOMA;

D O I：

10.1002/mco2.167

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the effort against the COVID-19 outbreak starting in late 2019, although the history of mRNA vaccines can be traced back decades. This review provides an overview to discuss the historical course and present situation of mRNA vaccine development in addition to some basic concepts that underly mRNA vaccines. We discuss the general preparation and manufacturing of mRNA vaccines and also discuss the scientific advances in the in vivo delivery system and evaluate popular approaches (i.e., lipid nanoparticle and protamine) in detail. Next, we highlight the clinical value of mRNA vaccines as potent candidates for therapeutic treatment and discuss clinical progress in the treatment of cancer and coronavirus disease 2019. Data suggest that mRNA vaccines, with several prominent advantages, have achieved encouraging results and increasing attention due to tremendous potential in disease management. Finally, we suggest some potential directions worthy of further investigation and optimization. In addition to basic research, studies that help to facilitate storage and transportation will be indispensable for practical applications.

引用

页数：31

共 302 条

[1] Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar [J].

Abu-Raddad, L. J. ;

Chemaitelly, H. ;

Ayoub, H. H. ;

AlMukdad, S. ;

Yassine, H. M. ;

Al-Khatib, H. A. ;

Smatti, M. K. ;

Tang, P. ;

Hasan, M. R. ;

Coyle, P. ;

Al-Kanaani, Z. ;

Al-Kuwari, E. ;

Jeremijenko, A. ;

Kaleeckal, A. H. ;

Latif, A. N. ;

Shaik, R. M. ;

Abdul-Rahim, H. F. ;

Nasrallah, G. K. ;

Al-Kuwari, M. G. ;

Butt, A. A. ;

Al-Romaihi, H. E. ;

Al-Thani, M. H. ;

Al-Khal, A. ;

Bertollini, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19) :1804-1816

[2] Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants [J].

Accorsi, Emma K. ;

Britton, Amadea ;

Fleming-Dutra, Katherine E. ;

Smith, Zachary R. ;

Shang, Nong ;

Derado, Gordana ;

Miller, Joseph ;

Schrag, Stephanie J. ;

Verani, Jennifer R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :639-651

[3] The SARS-CoV-2 N Protein Is a Good Component in a Vaccine [J].

Ahlen, Gustaf ;

Frelin, Lars ;

Nikouyan, Negin ;

Weber, Friedemann ;

Hoglund, Urban ;

Larsson, Olivia ;

Westman, Marie ;

Tuvesson, Ola ;

Gidlund, Eva-karin ;

Cadossi, Matteo ;

Appelberg, Sofia ;

Mirazimi, Ali ;

Sallberg, Matti .

JOURNAL OF VIROLOGY, 2020, 94 (18)

[4] Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics [J].

Ahmad, Sajjad ;

Navid, Afifa ;

Farid, Rabia ;

Abbas, Ghulam ;

Ahmad, Faisal ;

Zaman, Naila ;

Parvaiz, Nousheen ;

Azam, Syed Sikander .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 151

[5] The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs [J].

Akinc, Akin ;

Maier, Martin A. ;

Manoharan, Muthiah ;

Fitzgerald, Kevin ;

Jayaraman, Muthusamy ;

Barros, Scott ;

Ansell, Steven ;

Du, Xinyao ;

Hope, Michael J. ;

Madden, Thomas D. ;

Mui, Barbara L. ;

Semple, Sean C. ;

Tam, Ying K. ;

Ciufolini, Marco ;

Witzigmann, Dominik ;

Kulkarni, Jayesh A. ;

van der Meel, Roy ;

Cullis, Pieter R. .

NATURE NANOTECHNOLOGY, 2019, 14 (12) :1084-1087

[6]

Alameh M-G., 2022, RNA Therapeutics, P141, DOI 10.1016/B978-0-12-821595-1.00014-2

[7] Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial [J].

Alberer, Martin ;

Gnad-Vogt, Ulrike ;

Hong, Henoch Sangjoon ;

Mehr, Keyvan Tadjalli ;

Backert, Linus ;

Finak, Greg ;

Gottardo, Raphael ;

Bica, Mihai Alexandru ;

Garofano, Aurelio ;

Koch, Sven Dominik ;

Fotin-Mleczek, Mariola ;

Hoerr, Ingmar ;

Clemens, Ralf ;

von Sonnenburg, Frank .

LANCET, 2017, 390 (10101) :1511-1520

[8] Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial [J].

Aldrich, Cassandra ;

Leroux-Roels, Isabel ;

Huang, Katell Bidet ;

Bica, Mihai Alexandru ;

Loeliger, Edde ;

Schoenborn-Kellenberger, Oliver ;

Walz, Lisa ;

Leroux-Roels, Geert ;

von Sonnenburg, Frank ;

Oostvogels, Lidia .

VACCINE, 2021, 39 (08) :1310-1318

[9] COVID-19 vaccination: The road ahead [J].

Altmann, Daniel M. ;

Boyton, Rosemary J. .

SCIENCE, 2022, 375 (6585) :1127-1132

[10] Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications [J].

Amiri, Ala ;

Bagherifar, Rafieh ;

Dezfouli, Ehsan Ansari ;

Kiaie, Seyed Hossein ;

Jafari, Reza ;

Ramezani, Reihaneh .

JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)

← 1 2 3 4 5 6 7 8 9 10 →